Skip to content
Contact
Careers
About Us
Epigenetic Modulation
Clinical Development
Partnering & Technologies
Investors
Menu Toggle
Overview
News
SEC Filings
Stock Information
Events
FAQs
Corporate Governance
Resources
Main Menu
SEC Filings
[lsc-sec]
Investor Relations Contact
Contact: Sandya von der Weid
LifeSci Advisors
svonderweid@lifesciadvisors.com
Email Alerts Sign-Up
[lsc-email]
About Us
Menu Toggle
Overview
Leadership
Board of Directors
Epigenetic Modulation
Menu Toggle
Overview
Larsucosterol
How it Works
Broad Therapeutic Potential​
Clinical Development
Menu Toggle
Clinical Trials
Pipeline
Alcohol-Associated Hepatitis (AH)
Nonalcoholic Steatohepatitis (NASH)
Partnering & Technologies
Menu Toggle
Larsucosterol
POSIMIR®
ALZET Osmotic Pumps
Current Collaborations
Investors
Menu Toggle
Overview
News
SEC Filings
Stock Information
Events
Corporate Governance
Resources
Menu Toggle
Publications
Factsheets
Contact
Careers
FAQs
About Us
Menu Toggle
Overview
Leadership
Board of Directors
Epigenetic Modulation
Menu Toggle
Overview
Larsucosterol
How it Works
Broad Therapeutic Potential​
Clinical Development
Menu Toggle
Clinical Trials
Pipeline
Alcohol-Associated Hepatitis (AH)
Nonalcoholic Steatohepatitis (NASH)
Partnering & Technologies
Menu Toggle
Larsucosterol
POSIMIR®
ALZET Osmotic Pumps
Current Collaborations
Investors
Menu Toggle
Overview
News
SEC Filings
Stock Information
Events
Corporate Governance
Resources
Menu Toggle
Publications
Factsheets
Contact
Careers
FAQs
Scroll to Top
